Vitamin deficiency vertigo. Vitamin D Supplementation for Benign Paroxysmal Positional Vertigo: A Comprehensive Analysis

26.07.202308.07.2023 by alexxlab

How does vitamin D supplementation affect benign paroxysmal positional vertigo. What are the key findings of the longitudinal clinical study on vitamin D and BPPV. Can vitamin D deficiency contribute to vertigo symptoms. How does vitamin D influence muscle strength and balance in relation to BPPV.

Содержание

Understanding Benign Paroxysmal Positional Vertigo (BPPV)

Benign Paroxysmal Positional Vertigo (BPPV) is a common vestibular disorder characterized by brief episodes of vertigo triggered by changes in head position. While generally considered a benign condition, BPPV can significantly impact an individual’s quality of life and daily activities.

What causes BPPV? The condition results from the displacement of otoconia (tiny calcium carbonate crystals) within the inner ear’s semicircular canals. These misplaced crystals disrupt the normal fluid movement in the canals, leading to false signals about head position and movement being sent to the brain, ultimately causing vertigo.

BPPV is more prevalent in older adults
Symptoms include brief episodes of dizziness, nausea, and loss of balance
Diagnosis typically involves provocative maneuvers such as the Dix-Hallpike test

The Link Between Vitamin D and BPPV

Recent research has shed light on the potential relationship between vitamin D deficiency and the occurrence and severity of BPPV. Vitamin D plays a crucial role in calcium metabolism and bone health, which are closely linked to the function of the inner ear.

How does vitamin D deficiency potentially contribute to BPPV? Low levels of vitamin D may lead to reduced calcium absorption, potentially affecting the structure and function of the otoconia in the inner ear. This could make them more susceptible to dislodging and causing BPPV symptoms.

Key Findings from Recent Studies

A higher prevalence of vitamin D deficiency has been observed in BPPV patients compared to the general population
Patients with recurrent BPPV tend to have lower serum vitamin D levels
Vitamin D supplementation may reduce the recurrence rate of BPPV in deficient individuals

The Impact of Vitamin D on Muscle Function and Balance

Beyond its potential direct effects on the inner ear, vitamin D plays a significant role in muscle function and balance, which are crucial factors in managing BPPV symptoms and preventing falls.

How does vitamin D influence muscle strength and balance? Vitamin D receptors are present in muscle tissue, and adequate vitamin D levels are essential for maintaining muscle mass, strength, and function. Improved muscle function can contribute to better balance and reduced fall risk in individuals with BPPV.

Evidence from Clinical Studies

Vitamin D supplementation has been shown to improve muscle strength in deficient individuals
Higher vitamin D levels are associated with better postural stability in older adults
Vitamin D supplementation may reduce the risk of falls, particularly in elderly populations

Vitamin D Supplementation as a Potential Treatment for BPPV

The emerging evidence on the relationship between vitamin D and BPPV has led researchers to explore the potential benefits of vitamin D supplementation as a complementary treatment approach.

Can vitamin D supplementation improve BPPV outcomes? While more research is needed, initial studies suggest that correcting vitamin D deficiency through supplementation may have positive effects on BPPV symptoms and recurrence rates.

Potential Benefits of Vitamin D Supplementation in BPPV

Reduced frequency and severity of vertigo episodes
Lower recurrence rates of BPPV
Improved response to conventional BPPV treatments, such as the Epley maneuver
Enhanced overall balance and reduced fall risk

Optimal Vitamin D Levels for BPPV Management

Determining the ideal vitamin D levels for BPPV management is an area of ongoing research. While there is no universally agreed-upon optimal level specifically for BPPV, general recommendations for vitamin D sufficiency can serve as a guide.

What are the recommended vitamin D levels for overall health? The Endocrine Society suggests that a serum 25-hydroxyvitamin D concentration of at least 30 ng/mL (75 nmol/L) is necessary for optimal health benefits.

Factors Influencing Vitamin D Status

Sunlight exposure
Dietary intake
Age (older adults are at higher risk of deficiency)
Skin pigmentation
Geographical location and season

Implementing Vitamin D Supplementation in BPPV Treatment

Integrating vitamin D supplementation into BPPV treatment protocols requires careful consideration and should be done under medical supervision. The appropriate dosage and duration of supplementation may vary depending on individual factors and baseline vitamin D levels.

How should vitamin D supplementation be approached in BPPV patients? A comprehensive approach may include:

Assessing baseline vitamin D levels through blood tests
Determining appropriate supplementation dosage based on deficiency severity
Regular monitoring of vitamin D levels during treatment
Combining supplementation with conventional BPPV treatments
Educating patients on the importance of maintaining adequate vitamin D levels

Future Directions in Vitamin D and BPPV Research

While the current evidence suggests a promising link between vitamin D and BPPV, further research is needed to fully elucidate the relationship and optimize treatment strategies.

What areas of research should be prioritized? Future studies should focus on:

Large-scale, randomized controlled trials to confirm the efficacy of vitamin D supplementation in BPPV
Investigating the optimal vitamin D levels specifically for BPPV prevention and management
Exploring the potential synergistic effects of vitamin D supplementation with other BPPV treatments
Examining the long-term outcomes of vitamin D supplementation in BPPV patients
Investigating the molecular mechanisms underlying the relationship between vitamin D and inner ear function

As research in this field progresses, it is crucial for healthcare providers to stay informed about the latest findings and consider incorporating vitamin D assessment and management into their approach to BPPV treatment. By addressing vitamin D deficiency alongside conventional treatments, there is potential to improve outcomes and quality of life for individuals suffering from this common vestibular disorder.

The relationship between vitamin D and BPPV represents an exciting area of research with potential implications for both prevention and treatment strategies. As our understanding of this connection deepens, it may lead to more comprehensive and effective approaches to managing BPPV and related vestibular disorders.

In conclusion, while vitamin D supplementation shows promise as a complementary approach to BPPV management, it should not be considered a standalone treatment. The most effective strategy for managing BPPV likely involves a multifaceted approach that combines conventional treatments, such as repositioning maneuvers, with addressing underlying factors like vitamin D deficiency. As research in this field continues to evolve, it is essential for both healthcare providers and patients to stay informed about the potential benefits of maintaining optimal vitamin D levels in the context of vestibular health.

Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study

1. Heidari B, Heidari P, Samari E, Jalali MR. Frequency of vitamin D deficiency in common musculoskeletal conditions. J Babol Univ Med Sci. 2014;16:7–15. [in Persian] [Google Scholar]

2. Heidari B, Heidari P, Hajian-Tilaki K. High prevalence of vitamin D deficiency in women presenting to rheumatology clinic in north of Iran: An inverse relation with age. J Women’s Health Care. 2013;2:123. [Google Scholar]

3. Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian J Intern Med. 2011;2:205–12. [PMC free article] [PubMed] [Google Scholar]

4. Heidari B. Muscle strength, vitamin D deficiency and knee osteoarthritis. J Babol Univ Med Sci. 2012;14:84–91. [Google Scholar]

5. Heidari B. Knee osteoarthritis diagnosis, treatment and associated factors of progression: Part II. Casp J Intern Med. 2011;2:249–55. [PMC free article] [PubMed] [Google Scholar]

6. Heidari B, Heidari P, Tilaki KH. Relationship between unexplained arthralgia and vitamin D deficiency: a case control study. Acta Med Iran. 2014;52:400–5. [PubMed] [Google Scholar]

7. Heidari B, Javadian Y, Babaei M, Yousef Ghahari B. Restorative effect of vitamin D deficiency on knee pain and quadriceps muscle strength in knee osteoarthritis. Acta Med Iran. 2015;53:460–70. [PubMed] [Google Scholar]

8. Heidari B, Monadi M, Asgharpour M, et al. Efficiency of supplemental vitamin D in patients with chronic obstructive pulmonary disease. Br J Med Med Res. 2014;4:3031–41. [Google Scholar]

9. Silva C, Amorim AM, Paiva A. Benign paroxysmal positional vertigo–a review of 101 cases. Acta Otorrinolaringol Esp. 2015;66:205–9. [PubMed] [Google Scholar]

10. Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, Gomez-Fiñana M. Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol. 2005;262:507–11. [PubMed] [Google Scholar]

11. Iwasaki S, Yamasoba T. Dizziness and Imbalance in the Elderly: Age-related Decline in the Vestibular System. Aging Dis. 2014;6:38–47. [PMC free article] [PubMed] [Google Scholar]

12. Rejnmark L. Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials. Ther Adv Chronic Dis. 2011;2:25–37. [PMC free article] [PubMed] [Google Scholar]

13. Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2011;59:2291–300. [PubMed] [Google Scholar]

14. Hilton M, Pinder D. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2004;2:CD003162. [PubMed] [Google Scholar]

15. Nunez RA, Cass SP, Furman JM. Short- and long-termoutcomes of canalith repositioning for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2000;122:647–52. [PubMed] [Google Scholar]

16. West N, Hansen S, Møller MN, Bloch SL, Klokker M. Repositioning chairs in benign paroxysmal positional vertigo: implications and clinical outcome. Eur Arch Otorhinolaryngol. 2015 Mar 7; [Epub ahead of print] [PubMed] [Google Scholar]

17. Heidari B, Haji Mirghassemi MB. Seasonal variations in serum vitamin D according to age and sex. Caspian J Intern Med. 2012;3:535–40. [PMC free article] [PubMed] [Google Scholar]

18. Talaat HS, Kabel AH, Khaliel LH, Abuhadied G, El-Naga HA, Talaat AS. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2015 Sep 16; pii: S0385-8146(15)00203-5. doi: 10.1016/j.anl.2015.08.009. [Epub ahead of print] [PubMed] [Google Scholar]

19. Jeong SH, Kim JS, Shin JW, et al. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol. 2013;260:832–8. [PubMed] [Google Scholar]

20. Suzuki T. Frontiers in vitamin D; basic research and clinical application Vitamin D and falls. Clin Calcium. 2011;21:71–9. [PubMed] [Google Scholar]

21. Mastaglia SR, Seijo M, Muzio D, et al. Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J Nutr Health Aging. 2011;15:349–54. [PubMed] [Google Scholar]

22. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692. [PMC free article] [PubMed] [Google Scholar]

23. Boersma D, Demontiero O, Mohtasham Amiri Z, et al. Vitamin D status in relation to postural stability in the elderly. J Nutr Health Aging. 2012;16:270–5. [PubMed] [Google Scholar]

24. Cangussu LM, Nahas-Neto J, Orsatti CL, et al. Effect of isolated vitamin D supplementation on the rate of falls and postural balance in postmenopausal women fallers: a randomized, double-blind, placebo-controlled trial. Menopause. 2015 Nov 2; [Epub ahead of print] [PubMed] [Google Scholar]

25. Parham K, Leonard G, Feinn RS, et al. Prospective clinical investigation of the relationship between idiopathic benign paroxysmal positional vertigo and bone turnover: a pilot study. Laryngoscope. 2013;123:2834–9. [PubMed] [Google Scholar]

26. Talaat HS, Abuhadied G, Talaat AS, Abdelaal MS. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272:2249–53. [PubMed] [Google Scholar]

27. Yu S, Liu F, Cheng Z, Wang Q. Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review. BMC Neurol. 2014;14:110. [PMC free article] [PubMed] [Google Scholar]

28. Heidari B, Heidari P, Nourooddini HG, Hajian-Tilaki KO. Relationship between parity and bone mass in postmenopausal women according to number of parities and age. J Reprod Med. 2013;58:389–94. [PubMed] [Google Scholar]

29. Heidari B, Hoshmand S, Hajian K, Heidari P. Comparing bone mineral density in postmenopausal women with and without vertebral fracture and its value in recognizing high-risk individuals. East Mediterr Health J. 2010;16:868–73. [PubMed] [Google Scholar]

30. Heidari B, Javadian Y, Monadi M, Dankob Y, Firouzjahi A. Vitamin D status and distribution in patients with chronic obstructive pulmonary disease versus healthy controls. Caspian J Intern Med. 2015;6:93–7. [PMC free article] [PubMed] [Google Scholar]

31. Hajian-Tilaki K, Heidari B, Firouzjahi A, et al. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: a population-based study. Diabetes Metab Syndr. 2014;8:170–6. [PubMed] [Google Scholar]

32. Prasad P, Kochhar A. Interplay of vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr. 2015 Mar 6; pii: S1871-4021(15)00027-2. doi: 10.1016/j.dsx.2015 .02.014. [Epub ahead of print] [PubMed] [Google Scholar]

33. Hajian-Tilaki K, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years, in the north of Iran: a population-based study and regression approach. Obes Rev. 2007;8:3–10. [PubMed] [Google Scholar]

34. Hajian-Tilaki K, Heidari B. Childhood obesity, overweight, sociodemographic and life style determinants among preschool children in Babol, Northern Iran. Iran Public Health. 2013;42:1283–91. [PMC free article] [PubMed] [Google Scholar]

35. Hajian-Tilaki K, Heidari B. Prevalence of overweight and obesity and their association with physical activity pattern among Iranian adolescents aged 12-17 years. Public Health Nutr. 2012;15:2246–52. [PMC free article] [PubMed] [Google Scholar]

36. Waringhoff JC, Bayer O, Ferrari U, Straube A. Co-morbidities of vertiginous disease. BMC Neurol. 2009;9:29. [PMC free article] [PubMed] [Google Scholar]

37. Yamanka T, Fukuda T, Shirota S, et al. The prevalence and characteristics of metabolic syndrome in patients with vertigo. Plos One. 2013;8:e80176. [PMC free article] [PubMed] [Google Scholar]

Taking Vitamin D Twice a Day May Keep Vertigo Away

Research published August 2020 in Neurology, the journal of the American Academy of Neurology, describes the benefit of taking both vitamin D and calcium twice a day to decrease a recurrence of vertigo for individuals predisposed to experiencing this disconcerting and sometimes dangerous physiologic symptom.

Ji-Soo Kim, MD, PhD, of Seoul National University College of Medicine in Korea and colleagues examined nearly 1,000 individuals in Korea who were diagnosed with benign paroxysmal positional vertigo and who were subsequently successfully treated with therapeutic head movements. The authors describe benign paroxysmal positional vertigo as one of the most common types of vertigo (or dizziness), occurring when the position of the head changes and results in a “sudden spinning sensation. ” Treatment involves performing a series of head movements that are intended to shift particles in the ears that cause the vertigo; however, despite initial improvement, vertigo frequently recurs. The authors note that roughly 86% of people with this form of vertigo miss days at work and find that it interrupts their daily life.

“Our study suggests that for people with benign paroxysmal positional vertigo, taking a supplement of vitamin D and calcium is a simple, low-risk way to prevent vertigo from recurring,” said Dr. Kim, who added, “It is especially effective if you have low vitamin D levels to begin with.”

The 348 people of the 445 in the intervention group had vitamin D levels below 20 nanograms per milliliter (ng/mL) and received vitamin D supplementation of 400 international units of vitamin D and 500 milligrams of calcium twice daily. The remainder had levels equal to or greater than 20 ng/mL and were not given supplements. The observation group included 512 people who did not receive supplements and did not have their vitamin D levels monitored. The authors wrote that the intervention group showed a reduction in the absolute risk reduction [0.83 (95% CI, 0.74-0.92) vs. 1.10 (95% CI, 1.00-1.19) recurrences per one-person year with an incidence rate ratio of 0.76 (95% CI, 0.66-0.87, P <.001) and an absolute rate ratio of -0.27 (-0.40 to -0.14) from intention to treat analysis. The number needed to treat was 3.70 (95% CI, 2.50-7.14). The proportion of patients with recurrence was also lower in the intervention than in the observation group (37.8 vs. 46.7%, P = .005).

“Our results are exciting because so far, going to the doctor to have them perform head movements has been the main way we treat benign paroxysmal positional vertigo,” said Dr. Kim. “Our study suggests an inexpensive, low-risk treatment like vitamin D and calcium tablets may be effective at preventing this common, and commonly recurring, disorder.”

The authors observed a greater improvement in vertigo for patients who exhibited a greater vitamin D deficiency at the beginning of the study, with individuals starting at a level lower than 10 ng/mL experiencing a 45% reduction in annual recurrence rate. Comparatively, individuals with levels between 10 and 20 ng/mL experienced only a 14% reduction. A total of 38% of the people in the interventional group had another episode of vertigo, compared with 47% of those in the observation group. The authors noted that many subjects dropped out of study before it was completed, a limitation to the trial.

The content contained in this article is for informational purposes only. The content is not intended to be a substitute for professional advice. Reliance on any information provided in this article is solely at your own risk.

« Click here to return to Health Systems Update.

Vitamin D deficiency can cause dizziness attacks

Health

To find out, Egyptian scientists conducted a study on 40 patients diagnosed with benign paroxysmal positional vertigo. Translated into human – dizzy with a sharp change in posture.

August 24, 2021

Source:: iStock/Getty Images

About 20 percent of adults complain of dizziness. Many of them are not due to problems with neurology, but with disorders in the vestibular apparatus. Calcium carbonate crystals (otoconia) enter the semicircular canals and cause benign paroxysmal positional vertigo (BPPV). It occurs most often due to a change in the position of the head, tilting, turning when you get out of bed or lie down in it. Therefore, the disease has another name – positional vertigo. It can be accompanied by mild nausea, even vomiting, and does not last long – a few minutes. Scientists have suggested that the process may be affected by a lack of vitamin D.

“We set out to evaluate the association between recurrent BPPV attacks and vitamin D deficiency,” Aida Ahmed Abdelmaqsoud, co-author of the ENT department at the University of the South Valley School of Medicine, Egypt, explained the purpose of the study in the journal Nature.

Vitamin D and benign paroxysmal positional vertigo

PUBLICATIONS

Relevance

Benign paroxysmal positional vertigo (BPPV) is one of the most common diseases of the peripheral part of the vestibular analyzer. The main clinical manifestation of BPPV is intermittent short-term attacks of dizziness when the head position changes. It is believed that BPPV is the most common cause of dizziness (18-25% of all cases of dizziness).

Despite the benign nature of the disease, the presence of BPPV is associated with a decrease in the quality of life. However, there are no effective methods to prevent BPPV. Several observational studies have found that BPPV patients are more likely than the general population to have vitamin D deficiency and decreased bone mineral density. In this connection, the purpose of the study under discussion was to evaluate the effectiveness of vitamin D in the prevention of BPPV.

Methods

The randomized trial was performed in 8 hospitals in South Korea between December 2013 and May 2017.

Its participants were patients with BPPV. All of them were randomized into two groups: vitamin D therapy 400 IU in combination with 500 mg calcium carbonate twice a day (if the concentration of vitamin D was less than 20 ng/ml) and standard observation.

The primary end point was the annual recurrence rate. The mean follow-up period for participants was 1 year.

Results

The study participants were 1050 patients with BPPV.
It was found that, on average, during the study period, relapses of dizziness were observed with a frequency of 0.83 cases per year in the vitamin D group and 1.1 cases per year in the standard observation group (hazard ratio 0.76; 95% confidence interval 0.66-0.87; p<0.001. In addition , in the active therapy group, BPPV relapses were reported in fewer patients (37.8% vs. 46.7%; p=0.005).
The estimated number of patients who needed to be treated with vitamin D to prevent recurrence of BPPV was 3.7 (95% CI 2.5-7.14).

Conclusion

Thus, the results of the present study demonstrate that in patients with BPPV, vitamin D and calcium supplementation reduces the frequency of relapses. Probably, their administration can be considered as a way to prevent dizziness in patients with calcium deficiency and frequent relapses of BPPV.